NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Akorn (AKRX) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $14 price target.
ArthroCare Corporation (ARTC) upgraded to buy at TheStreet Ratings.Astec Industries (ASTE) upgraded to buy at TheStreet Ratings. Berkshire Hathaway (BRK.A) upgraded to buy at TheStreet Ratings. Cinemark (CNK) rated new Neutral at Goldman. $15 price target. U.S. movie demand and pricing growth is slowing. Cablevision (CVC - Get Report) upgraded at BofA/Merrill to Buy, Bank of America/Merrill Lynch said. $18 price target. Growth could accelerate, after a year of underperformance. Cypress Semiconductor (CY) upgraded at Cantor from Sell to Hold, Cantor Fitzgerald said. Valuation call, based on an $11 price target. Deckers (DECK) downgraded at Sterne Agee to Underperform, Sterne Agee said. $38 price target. Estimates cut, given lower likely international sales. Fifth Third (FITB) upgraded at Compass Point from Neutral to Buy, Compass Point said. Valuation call, based on a $17 price target. Illumina (ILMN) upgraded at Leerink from Market Perform to Outperform, Leerink Swann said. Company has multiple potential catalysts. Imax (IMAX) rated new Buy at Goldman. $30 price target. Company is growing faster than its peers and is leveraged to China. KB Home (KBH) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $15 price target. Rising home prices should drive new housing starts. Mosaic (MOS) upgraded at Citigroup to Buy from Neutral, Citigroup said. $66 price target. Also added to TPL! list. Demand for fertilizers is strong with drought. NVR (NVR - Get Report) downgraded at Goldman to Sell, Goldman Sachs said. $760 price target. Company is facing increased competition. Onyx Pharmaceuticals (ONXX) upgraded at Jefferies to Buy from Hold, Jefferies said. $101 price target. Improved outlook with limited downside. Buy rating. Penn National (PENN - Get Report) downgraded at Keybanc from Buy to Hold, Keybanc said. Valuation call, as consumer sentiment is weakening. Ryland (RYL) upgraded at Goldman to Neutral, Goldman Sachs said. $34 price target. Estimates also boosted, given higher industry pricing. Schlumberger (SLB - Get Report) upgraded at Argus from Hold to Buy, Argus Research said. $85 price target. International and deepwater markets should drive growth.